Security key
75974E103
OnKure Therapeutics, Inc. - Common Stock, $0.0001 Par Value (RPHM)
CUSIP: 75974E103
Q4 2025 13F Holders as of 31 Dec 2025
- Security type / class
- Equity / Common Stock, $0.0001 Par Value
- Total 13F shares
- 504
- Total 13F value
- $1,462
- Share change
- 0
- SEC-reported price per share
- $2.90
- Number of holders
- 1
- Shares outstanding
- 41,305,653
Holder snapshot
3 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q4 2025
Institutions
1
Top holders
1
RPHM full security history
Ownership snapshot
Full 13F holder table
Newer quarter: Q1 2026
Previous quarter: Q3 2025
OnKure Therapeutics, Inc. SEC filings
OnKure Therapeutics, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 75974E103
Recent filing periods:
Ownership snapshot
Top reported holders of RPHM - OnKure Therapeutics, Inc. - Common Stock, $0.0001 Par Value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
ACORN BIOVENTURES, L.P.
Disclosed value leader
ACORN BIOVENTURES, L.P.
Comparable rows
15/15
Latest evidence
24 Nov 2025
3/4/5
13D/G
13F
Lead comparable stake: 22%
13D/G row: ACORN BIOVENTURES, L.P.
Showing 1-6 of 15 holder rows.
Quick read
ACORN BIOVENTURES, L.P. leads the comparable SEC ownership view at 22%.
15 of 15 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens ACORN BIOVENTURES, L.P.'s linked filing trail.
Comparable ownership
Top 5
ACORN BIOVENTURES, L.P.
22%
Shay Capital LLC
6.3%
Prosight Management, LP
5.8%
CANTOR FITZGERALD & CO.
5.2%
VANGUARD GROUP INC
4.9%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 15 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| ACORN BIOVENTURES, L.P. |
3/4/5
13D/G
10%+ Owner · Anders Hove
|
22%
from 13D/G
|
$9,098,765
4,279,348 shares
mixed-class rows
|
— | 15 May 2025 |
| Shay Capital LLC |
13F
13D/G
Company
|
6.3%
from 13D/G
|
$2,524,319
917,934 shares
|
— | 30 Sep 2025 |
| Prosight Management, LP |
13D/G
13F
Company
|
5.8%
|
$2,214,578
745,649 shares
|
$0 | 24 Nov 2025 |
| CANTOR FITZGERALD & CO. |
13D/G
Cantor Fitzgerald Securities
|
5.2%
|
$1,606,894
669,539 shares
|
$0 | 30 Jun 2025 |
| VANGUARD GROUP INC |
13F
13D/G
Company · The Vanguard Group
|
4.9%
from 13D/G
|
$1,865,122
678,226 shares
|
— | 30 Sep 2025 |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC |
13F
13D/G
Company
|
4.2%
from 13D/G
|
$1,788,100
650,218 shares
|
— | 30 Sep 2025 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q4 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
1
Shares
504
Rows available
1
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q4 2025 vs Q3 2025 Across Filers
Q3 2025 holders
1
Q4 2025 holders
1
Holder diff
0
| Investor | Q3 2025 Shares | Q4 2025 Shares | Share Diff | Share Chg % | Q3 2025 value | Q4 2025 value | Value change | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend